MR-vejledt laserablation til behandling af hjernetumorer og epilepsi

Silas Haahr Nielsen; Morten Ziebell; Adam Espe Hansen; Jane Skjøth-Rasmussen; Gorm B von Oettingen; Lars Hageman Pinborg; Bo Jespersen; Søren Møller; Rune Rasmussen

MR-vejledt laserablation til behandling af hjernetumorer og epilepsi

Translated title of the contribution: MR-guided laser interstitial thermal therapy in the treatment of brain tumours and epilepsy

Silas Haahr Nielsen^*, Morten Ziebell, Adam Espe Hansen, Jane Skjøth-Rasmussen, Gorm B von Oettingen, Lars Hageman Pinborg, Bo Jespersen, Søren Møller, Rune Rasmussen

^*Corresponding author for this work

1 Citation (Scopus)

Abstract

MR-guided laser interstitial thermal therapy (LITT) is a minimally invasive neurosurgical procedure, which in the last decade has gained significant momentum of the treatment of intracranial tumours and epileptic foci. In brief, LITT utilises the heat from a stereotactically placed laser catheter to selectively ablate a lesion or a structure under real-time MRI guidance, which is summarised and discussed in this review. The first LITT system gained FDA approval in 2007 and was CE-marked in 2018. In December 2020, the first patient with recurrent glioblastoma was treated at the Department of Neurosurgery at Rigshospitalet, Copenhagen.

Translated title of the contribution	MR-guided laser interstitial thermal therapy in the treatment of brain tumours and epilepsy
Original language	Danish
Article number	V02210128
Journal	Ugeskrift for Laeger
Volume	183
Issue number	22
ISSN	0041-5782
Publication status	Published - 15 Nov 2021

Cite this

@article{e4e99cfe5abe4587bfc158bb01e09e85,

title = "MR-vejledt laserablation til behandling af hjernetumorer og epilepsi",

abstract = "MR-guided laser interstitial thermal therapy (LITT) is a minimally invasive neurosurgical procedure, which in the last decade has gained significant momentum of the treatment of intracranial tumours and epileptic foci. In brief, LITT utilises the heat from a stereotactically placed laser catheter to selectively ablate a lesion or a structure under real-time MRI guidance, which is summarised and discussed in this review. The first LITT system gained FDA approval in 2007 and was CE-marked in 2018. In December 2020, the first patient with recurrent glioblastoma was treated at the Department of Neurosurgery at Rigshospitalet, Copenhagen.",

keywords = "Brain Neoplasms/diagnostic imaging, Epilepsy/surgery, Humans, Laser Therapy, Lasers, Magnetic Resonance Imaging, Neoplasm Recurrence, Local/surgery",

author = "Nielsen, {Silas Haahr} and Morten Ziebell and Hansen, {Adam Espe} and Jane Skj{\o}th-Rasmussen and {von Oettingen}, {Gorm B} and Pinborg, {Lars Hageman} and Bo Jespersen and S{\o}ren M{\o}ller and Rune Rasmussen",

year = "2021",

month = nov,

day = "15",

language = "Dansk",

volume = "183",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "22",

}

TY - JOUR

T1 - MR-vejledt laserablation til behandling af hjernetumorer og epilepsi

AU - Nielsen, Silas Haahr

AU - Ziebell, Morten

AU - Hansen, Adam Espe

AU - Skjøth-Rasmussen, Jane

AU - von Oettingen, Gorm B

AU - Pinborg, Lars Hageman

AU - Jespersen, Bo

AU - Møller, Søren

AU - Rasmussen, Rune

PY - 2021/11/15

Y1 - 2021/11/15

N2 - MR-guided laser interstitial thermal therapy (LITT) is a minimally invasive neurosurgical procedure, which in the last decade has gained significant momentum of the treatment of intracranial tumours and epileptic foci. In brief, LITT utilises the heat from a stereotactically placed laser catheter to selectively ablate a lesion or a structure under real-time MRI guidance, which is summarised and discussed in this review. The first LITT system gained FDA approval in 2007 and was CE-marked in 2018. In December 2020, the first patient with recurrent glioblastoma was treated at the Department of Neurosurgery at Rigshospitalet, Copenhagen.

AB - MR-guided laser interstitial thermal therapy (LITT) is a minimally invasive neurosurgical procedure, which in the last decade has gained significant momentum of the treatment of intracranial tumours and epileptic foci. In brief, LITT utilises the heat from a stereotactically placed laser catheter to selectively ablate a lesion or a structure under real-time MRI guidance, which is summarised and discussed in this review. The first LITT system gained FDA approval in 2007 and was CE-marked in 2018. In December 2020, the first patient with recurrent glioblastoma was treated at the Department of Neurosurgery at Rigshospitalet, Copenhagen.

KW - Brain Neoplasms/diagnostic imaging

KW - Epilepsy/surgery

KW - Humans

KW - Laser Therapy

KW - Lasers

KW - Magnetic Resonance Imaging

KW - Neoplasm Recurrence, Local/surgery

UR - https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-06/v02210128_web.pdf

M3 - Tidsskriftartikel

C2 - 34169824

VL - 183

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 22

M1 - V02210128

ER -

MR-vejledt laserablation til behandling af hjernetumorer og epilepsi

Abstract

Other files and links

Fingerprint

Cite this